Navigation Links
Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
Date:5/21/2010

ity/running around excessively, arguing with adults, and losing temper.  INTUNIV is a non-scheduled medication and has no known potential for abuse or dependence.   INTUNIV is available in US pharmacies in four dosage strengths:  1 milligram (mg), 2 mg, 3 mg, and 4 mg.  

INTUNIV Co-Administered With a Stimulant Demonstrated Significant Symptom Improvement vs. Stimulant Alone

This 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-optimized phase III study enrolled patients aged 6 to 17 years with a diagnosis of ADHD and suboptimal response* to treatment with a long-acting stimulant.

Throughout the study, patients continued to take their same once-daily dose of a long-acting stimulant and were randomized to three treatment arms:  INTUNIV dosed in the morning, INTUNIV dosed in the evening, or placebo.  A total of 455 patients were evaluated for efficacy and safety.  The study consisted of 5 weeks of dose optimization and 3 weeks of dose maintenance.  INTUNIV was optimized up to 4 mg per day.  

The primary efficacy analysis was the change from baseline in ADHD-RS-IV total score at end point.  ADHD-RS-IV is a standardized test for evaluating symptoms of ADHD and assessing response to treatment.   At baseline, mean ADHD-RS-IV total scores were 37.6, 37.0, and 37.7 for the INTUNIV AM/stimulant, INTUNIV PM/stimulant, and placebo/stimulant treatment groups, respectively.  At study end, mean ADHD-RS-IV total scores were 17.3, 16.1, and 21.7, respectively.  Placebo-adjusted least squares (LS) mean change from baseline at end point for ADHD-RS-IV total score was a decrease of 4.5 (P=.002) for the INTUNIV AM/stimulant and a decrease of 5.3 (P<.001) for the INTUNIV PM/stimulant.

In this s
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
2. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
3. New Study Shows ENJUVIA® Significantly Reduced Sleep Time Awakenings Caused by Hot Flashes in Postmenopausal Women
4. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
5. Whistleblower Lawyers Comment on New England Journal of Medicine Study
6. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
7. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
8. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
9. Spiral Enteroscopy is Three Times Faster than Double-Balloon Enteroscopy in Diagnosing the Small Intestine, New Study Finds
10. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
11. BetterInvesting Magazine Releases Julys Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation ... its Investigational New Drug Application (IND) to evaluate ... the U.S. Food and Drug Administration (FDA). OMS824 ... in areas of the brain linked to a ... Huntington,s disease and schizophrenia. OMS824 has shown promising ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
... N.D., Dec. 16, 2011  Crystal3 Labs, Inc., a cGMP contract ... today that it has been acquired by an individual ... of the transaction were not disclosed. The company also ... Founded in 2007, Global Pharma Analytics provides ...
... ( Medical Device and Diagnostic Industry , UBM ... latest news , information, and in-depth analysis, announced a series of ... of medical device design.  "We,re taking a close ... industry," stated Brian Buntz, Editor for MD+DI. "To some, the focus ...
Cached Medicine Technology:Crystal3 Labs Acquired by Individual Investor, Vithalbhai Dhaduk, M.D. 2MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation 2MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation 3
(Date:5/23/2013)... 2013 The sodium theory ... and B. Katz in the early 1950s, after their ... of sodium and potassium ions in nerve functions ... acquisition techniques have known amazing developments. In The Sodium ... give an account of the latest developments in the ...
(Date:5/23/2013)... 2013 Orange County film studio and visual ... light leaks for Apple's Final Cut Pro X ... you no longer have to worry about matching up the ... shot," Said Christina Austin, CEO of Pixel Film Studios, "You ... natural look." , ProLeak from Pixel Film Studios allows users ...
(Date:5/23/2013)... Dr. Damon Huffman of Huffman Family Dentistry is ... a revolutionary new treatment method with the Laser Assisted New ... suffer from periodontal disease, and many of them do not ... is hoping that LANAP will encourage many of those people ... , Periodontal disease can cause gums to recede and even ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Funeral Financials ... Memorial Day to the EOD Memorial Foundation ... be the greatest victims from the war. , ... originated in 1941 before the U.S. was even at ... Forces are identified with the Explosive Ordnance Disposal Badge. ...
(Date:5/23/2013)... Lake City, UT (PRWEB) May 23, 2013 ... 3.0 , a comprehensive radiology learning environment for ... with prebuilt lessons and assessments, transforms the learning ... comprehensive radiology curriculum. , “Until RADPrimer ... is second to none,” comments Dr. B.J. Manaster, ...
Breaking Medicine News(10 mins):Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2
... African swine fever, a devastating pig disease that could ... Organisation said Friday. ,"This is a dramatic ... the Rome-based FAO, noting that the highly contagious viral ... since 1990." ,Armenia, Azerbaidjan and Russia "should ...
... survivors can halve the risk of dying from the disease ... of their weight, suggests a longitudinal study from the ... (UCSD). ,Published in the Journal of Clinical Oncology, ... of a combination of both healthy diet and physical activity ...
... aging in fruit flies with a new technique that shows ... triumph for pests, scientists have found out how to make ... may still have something for humans. As reported online in ... slow down aging holds implications for humans prolonged existence and ...
... diagnosed cancer in men. More than 218,000 men will be ... 27,000 will die . June is Prostate Cancer Awareness Month, ... about the ways men can keep their prostates healthy and ... caused by benign prostatic enlargement affect the vast majority of ...
... department of Health today confirmed the death of a Madison County ... case in 2007 and it seems to be much earlier ... due to the virus. ,Four Mississippians have contracted West ... according to the Health Department and the Centers for Disease Control ...
... gave birth to twins at a hospital in London, where she ... ,The 47-year-old and her husband of ten years, Paul Berges, ... only next month. ,Predicting the early arrival of twins, ... and that she and Berges are really thrilled about it. ...
Cached Medicine News:Health News:Healthy Diet, Exercise can Halve the Risk of Mortality in Breast Cancer Survivors 2Health News:Super Fruit Fly may Harbor Hope for Human Longevity 2Health News:Tips to Maintain a Healthy Prostate 2Health News:First Case of West Nile Virus Death in Madison County 2
... nonsurgical, physician-administered treatment that can temporarily smooth ... brows in people from 18 to 65 ... treatment of its type approved by the ... Cosmetic is a purified protein produced by ...
... is a non-animal stabilized hyaluronic acid-based ... filler to enter the U.S. market. ... moderate to severe facial wrinkles and ... is injected just under the skins ...
... SCULPTRA™ is an injectable ... poly-L-lactic acid, a biocompatible, biodegradable, ... family. SCULPTRA is reconstituted prior ... of Sterile Water for Injection, ...
... is clinically proven to reduce the appearance ... cream-gel formula combines Retinol, the purest form ... Caffeine. It works deep within skin's surface ... bumpy appearance. Fast absorbing, it has a ...
Medicine Products: